Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - AYTU BIOPHARMA, INC | f8k102218_aytubioscience.htm |
Exhibit 16.1
October 22, 2018
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read Aytu BioScience, Inc.’s statements included under Item 4.01 of its Form 8-K filed on October 22, 2018 and we agree with such statements concerning our firm.
EKS&H LLLP